Faruqi & Faruqi Secures Eye-Popping $750 Million Settlement

On May 27, 2020 the Honorable Colleen McMahon of the U.S. District Court for the Southern District of New York approved a historically large settlement between Forest Laboratories and direct purchasers of the drug Namenda, represented by Faruqi & Faruqi, LLP and others.  Counsel aggressively prosecuted this uniquely complicated antitrust case for over four-and-a-half years and reached the agreement to settle on the evening prior to jury selection giving plaintiffs “an outstanding recovery” according to Judge McMahon.  The $750 million settlement was the largest amount ever paid by a single defendant in a Hatch-Waxman antitrust suit alleging impaired generic competition.  Indeed, one legal analyst described the settlement as “among the most eye-popping sums ever shelled out by a drugmaker” in such a suit. 

The case is In Re Namenda Direct Purchaser Antitrust Litigation, No. 15-cv-07488 (S.D.N.Y.).

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania